ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Analysis of the value of novel inflammatory indicators derived from complete blood count in predicting for pertussis in children.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Complete Blood Count-Derived Inflammatory Markers in Pediatric Lower Respiratory Tract Infection: A Narrative Review.Pathogens (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveInflammatory indicators derived from complete blood count (CBC) have been shown to exhibit substantial clinical utility across a broad spectrum of infectious and inflammatory conditions, this study aimed to explore the potential value of CBC-derived inflammatory indicators in predicting for pertussis in children.
methodsCBC parameters of all the participants included in this study were collected. The CBC-derived inflammatory indicators evaluated included the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), [neutrophil + monocyte]-to-lymphocyte ratio (NMLR), systemic immune-inflammation index (SII), and systemic inflammatory response index (SIRI). The predictive value of CBC-derived inflammatory indicators was assessed using the receiver operating characteristic (ROC) curve analysis.
resultsA total of 892 pertussis children, 903 children with non-pertussis respiratory tract infection and 1,165 healthy children were included in this study. Compared to healthy children, the PLR in children with pertussis was significantly reduced (p < 0.001), whereas the levels of the other indicators were significantly increased. Simultaneously, the indicators in children with pertussis were significantly lower than those in children with non-pertussis infection. In the comparative analysis of inflammatory indicators across different age subgroups, all indicators in the pertussis group were significantly elevated in children < 2 years old, compared to those in both the non-pertussis group and the healthy group; conversely, in children > 2 years old, these indicators were significantly lower than those observed in the non-pertussis group. The ROC analysis results indicated that, aside from PLR, the CBC-derived inflammatory indicators demonstrated significant value in predicting for pertussis infection in children < 2 years old. Furthermore, the integration of multiple markers could enhance diagnostic performance.
conclusionCBC-derived inflammatory indicators, particularly NLR and NMLR, may serve as valuable tools for early predicting for pertussis in children under 2 years old in clinical practice.
Indexed as
Identifiers
40884593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.